Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwan Advance Bio Pharmaceutical IncfiledCriticalTaiwan Advance Bio Pharmaceutical Inc
Priority to TW95117012ApriorityCriticalpatent/TWI309239B/en
Publication of TW200742745ApublicationCriticalpatent/TW200742745A/en
Application grantedgrantedCritical
Publication of TWI309239BpublicationCriticalpatent/TWI309239B/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The present invention relates to monoclonal antibodies specific to enrofloxacin, a hybridoma cell line producing the antibodies, a kit containing the antibodies, and the detection of enrofloxacin using the antibodies, hybridoma cell line, or kit.
TW95117012A2006-05-122006-05-12Monoclonal antibody specific to enrofloxacin, hybridoma producing same and kit comprising same
TWI309239B
(en)